Comparison 15. Sensitivity analysis: antenatal (± postnatal) prophylaxis with LMWH versus UFH.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
15.1 Symptomatic thromboembolic events | 1 | 105 | Risk Ratio (M‐H, Fixed, 95% CI) | Not estimable |
15.2 Symptomatic pulmonary embolism | 1 | 105 | Risk Ratio (M‐H, Fixed, 95% CI) | Not estimable |
15.3 Symptomatic deep vein thrombosis | 1 | 105 | Risk Ratio (M‐H, Fixed, 95% CI) | Not estimable |